【导读】花小伟加盟国盛证券研究所 （图片来源：陆家嘴金融沙龙） 公开履历显示，花小伟具有十余年券商从业和产业研究经历，曾在银河证券、中信建投、红塔证券、德邦证券等多家券商任职，长期深耕大消费领域，覆 盖纺织服装、零售、轻工家居、食品饮料等多个细分行业。 在中信建投期间，其所在研究小组曾在轻工造纸领域连续四年登榜新财富分析师评选，并在2017年和2018年均获得第三名的成绩。 2020年底，在短暂加入红塔证券后，花小伟选择与红塔证券原研究所所长任志强一同转战德邦证券，出任研究所副所长兼大消费组组长及食品饮料、轻工 制造首席分析师。2022年12月，花小伟正式出任上海证券研究所所长，全面主持研究团队的运营管理、人才建设与战略规划。 记者注意到，此次花小伟还担任服务江西实体经济小组负责人。据了解，这是国盛证券研究所新设立的一个小组，职能类似其他券商旗下的产业研究院。 分析人士告诉记者，分析师的工作早已不再局限于个股与行业分析，而是深度参与国家战略、区域经济与产业发展研究，为政府决策、企业战略规划提供 专业支持。尤其是区域券商的研究所，纷纷担起当地"智库"的重任。例如，西南证券将研究所升级为研究院，利用卖方研究资源开 ...

第四季度报告作为年度收官和"十五五"开局前瞻，对国内外经济形势的分析更为全面，西南证券首席经 济学家叶凡认为，应积极主动把握以下几点内容：一是确认全年GDP增长5%等主要目标顺利实现，"十 四五"圆满收官。金融数据表明，适度宽松的货币政策有效支持了实体经济，融资成本低位下行，信贷 结构持续优化。这为下一阶段政策延续提供了实证基础，也坚定了政策定力。二是明确"继续实施好适 度宽松的货币政策"，确保社会融资条件"相对宽松"，使金融总量增长与经济增长、物价预期目标"相匹 配"。这传递了政策连续性和稳定性的明确信号，旨在稳定市场预期。三是将"扎实做好金融'五篇大文 章'"置于突出位置。不仅回顾了科技、绿色、普惠、养老、数字金融等领域贷款的快速增长，更通过专 栏和具体工具描述，揭示了政策重心从总量宽松向结构优化深化的路径。特别是通过再贷款、风险分担 工具与财政贴息、担保的协同，直接激励和引导金融资源流向科技创新、中小微企业、服务消费等扩大 内需和高质量发展的关键领域。四是强调深化利率市场化改革，引导融资成本"低位运行"。重申有管理 的浮动汇率制度，强调"风险中性"和"基本稳定"。宏观审慎与金融稳定委员会的设立、对重点领 ...

Group 1 - The Chongqing state-owned enterprise reform sector increased by 0.61% compared to the previous trading day, with Qianli Technology leading the gains [1] - On the same day, the Shanghai Composite Index closed at 4131.98, up 0.09%, while the Shenzhen Component Index closed at 14160.93, down 0.35% [1] - The trading volume and turnover for Qianli Technology were 347,300 shares and 369 million yuan, respectively, with a price increase of 2.22% [1] Group 2 - The net outflow of main funds in the Chongqing state-owned enterprise reform sector was 2.3995 million yuan, while retail investors saw a net inflow of 4.728 million yuan [2] - The trading data indicates that Qianli Technology had a net inflow of 25.4663 million yuan from main funds, while retail investors had a net outflow of 1.3324 million yuan [3] - The overall performance of stocks in the sector showed mixed results, with some stocks like Qianli Technology and Sanfeng Environment experiencing gains, while others like Chongqing Port and Chongqing Water experienced losses [3]

2026 年 2 月 10 日 行业研究/行业周报 非银行金融行业近一年市场表现 资料来源：常闻 【山证非银行金融】建设金融强国，关 注板块投资价值-【山证非银】行业周报 （20260126-20260201）： 2026.2.5 【山证非银行金融】公募业绩基准出台， 关注板块投资价值-【山证非银】行业周 报（20260119-20260125）： 2026.1.29 分析师： 刘丽 执业登记编码：S0760511050001 电话：0351--8686985 邮箱：liuli2@sxzq.com 孙田田 执业登记编码：S0760518030001 电话：0351-8686900 邮箱：suntiantian@sxzq.com 彭皓辰 执业登记编码：S0760525060001 邮箱：penghaochen@sxzq.com 非银行金融 行业周报（20260202-20260208） 领先大市-A(维持)) 修订发行承销监管指引，关注板块投资价值 投资要点 相关报告： 沪深交易所修订发行承销违规行为监管指引。沪深交易所分别 修订了《发行承销违规行为监管指引》，完善监管标准与违规情形， 提升发行承销监管的规范性 ...

Group 1 - The core transaction details indicate that Southwest Securities executed a block trade of 780,000 shares on February 10, with a total transaction value of 3.354 million yuan, representing 2.69% of the total trading volume for that day [1][2] - The transaction price was set at 4.3 yuan per share, which reflects a discount of 6.52% compared to the market closing price of 4.6 yuan [1][2] - The buying party for this transaction was Tianfeng Securities Co., Ltd. Shenzhen Branch, while the selling party was Zhongshan Securities Co., Ltd. Hubei Branch [2]

Market Overview - The Chongqing state-owned enterprise reform sector declined by 0.7% compared to the previous trading day, with Chongqing Pharmaceutical Holdings leading the decline [1] - The Shanghai Composite Index closed at 4128.37, up 0.13%, while the Shenzhen Component Index closed at 14210.63, up 0.02% [1] Stock Performance - Notable stock performances include: - Shanghai Sanmao (600689) closed at 14.29, up 0.78% with a trading volume of 30,300 shares and a turnover of 43.27 million yuan - Chongqing Construction (600939) closed at 3.23, up 0.31% with a trading volume of 133,800 shares and a turnover of 43.05 million yuan - Chongqing Pharmaceutical Holdings (000950) closed at 5.90, down 1.83% with a trading volume of 366,700 shares and a turnover of 218 million yuan [1][2] Capital Flow - The Chongqing state-owned enterprise reform sector experienced a net outflow of 119 million yuan from institutional investors, while retail investors saw a net inflow of 62.65 million yuan [2] - The capital flow for individual stocks shows: - Jieling Pickled Vegetables (002507) had a net inflow of 5.71 million yuan from institutional investors, but a net outflow of 13.01 million yuan from retail investors [3] - Chongqing Water (601158) had a net outflow of 3.40 million yuan from institutional investors, with a net inflow of 1.18 million yuan from retail investors [3]

Core Insights - The report from Southwest Securities indicates that first-line treatment for driver gene-negative NSCLC (non-small cell lung cancer) patients primarily relies on PD(L)-1 ± chemotherapy, with projected market sizes for immune drugs in this segment reaching approximately 7.5 billion yuan in China and 18 billion yuan in the U.S. by 2030 [1] Group 1: Market Overview - The driver gene-negative segment accounts for 31% of newly diagnosed NSCLC patients in both China and the U.S. [1] - The projected market size for immune drugs used in first-line treatment of driver gene-negative NSCLC is estimated to be around 7.5 billion yuan in China and 18 billion yuan in the U.S. by 2030 [1] Group 2: Next-Generation Immunotherapy - Next-generation immunotherapy options for NSCLC are advancing, including bispecific antibodies and IO+ADC (immuno-oncology plus antibody-drug conjugates) [2] - Current PD(L)-1 drugs, such as Pembrolizumab and Atezolizumab, have established their clinical position but face limitations in long-term efficacy, particularly in patients with low PD-L1 expression [2] Group 3: Bispecific Antibody Treatment - Bispecific antibodies can bind to two antigens or epitopes, balancing safety and efficacy, with the approval of Ivorisumab in 2024 expected to stimulate interest in PD-(L)1/VEGF therapies [3] - The clinical data and technological pathways for bispecific antibodies are gaining recognition, with the potential for tri-specific antibodies to become a new trend in immuno-oncology treatment [3] Group 4: IO+ADC Treatment - ADCs combine cytotoxic drugs with monoclonal antibodies targeting tumors, offering precise delivery and effective treatment with lower toxicity [3] - Clinical results for TROP2 ADC combined with K-drug show comparable ORR and PFS data to K-drug plus chemotherapy, providing new solutions for patients intolerant to chemotherapy [3]

Core Viewpoint - The company is centralizing its financial management functions at its headquarters to enhance operational efficiency and support business development [1] Group 1: Financial Management Strategy - The company has established a financial shared service center under its finance department to streamline financial operations [1] - The company is implementing technologies such as OCR intelligent recognition, one-click tax reporting, bank-enterprise direct connection, and imaging systems to improve the standardization and automation of financial processes [1] Group 2: Digital Transformation - The company aims to continuously optimize its financial management system in response to external environmental changes and internal management needs [1] - The focus is on accelerating the digital transformation of finance to enhance automation and intelligence, thereby promoting high-quality development [1]

1. Report Industry Investment Rating - Not provided in the given content 2. Report's Core View - The bond market is continuously recovering, with the net inflow of interest - rate bond ETFs turning positive. The scale of interest - rate bond and credit - bond ETFs may increase in the future. Short - term financing ETFs are favored due to year - end cash withdrawal and redemption needs, and there may be an opportunity for incremental funds in science - innovation bond ETFs and benchmark market - making credit - bond ETFs after the Chinese New Year [2][6]. 3. Summary According to Relevant Catalogs 3.1 各类债券 ETF 资金净流入情况 (Net Inflow of Funds for Various Bond ETFs) - The bond market is in continuous recovery, and the net inflow of interest - rate bond ETFs has turned positive. Last week, the net inflow of funds for interest - rate bond ETFs, credit - bond ETFs, and convertible - bond ETFs was +1.268 billion yuan, - 7.003 billion yuan, and +1.096 billion yuan respectively, with a total net inflow of - 4.639 billion yuan in the bond ETF market. The scale of the bond ETF market is 721.328 billion yuan, down 0.57% from the previous week's close and 13.01% from the beginning of the year, but its proportion in the total ETF market has increased by 28bp [2][5]. - Short - term financing ETFs, treasury - bond ETFs, and convertible - bond ETFs led in terms of net inflow of funds last week, with amounts of +3.256 billion yuan, +1.293 billion yuan, and +1.096 billion yuan respectively. Science - innovation bond ETFs and benchmark market - making credit - bond ETFs had relatively large net outflows, with amounts of - 8.056 billion yuan and - 2.453 billion yuan respectively [6]. 3.2 各类债券 ETF 份额及代表产品净值走势 (Share and Net Value Trends of Representative Products of Various Bond ETFs) - The shares of short - term financing ETFs and treasury - bond ETFs have increased. As of February 6, 2026, the shares of treasury - bond, policy - financial bond, local - bond, benchmark market - making credit - bond, science - innovation bond, corporate - bond, short - term financing, urban investment - bond, and convertible - bond ETFs changed by +1.8%, 0.0%, - 0.2%, - 2.3%, - 2.8%, 0.0%, +5.0%, +0.9%, and +1.5% respectively compared to the previous week's close, with a total change of +0.3% for bond - type ETFs [12][20]. - The net values of major bond ETFs generally increased, while the net value of convertible - bond ETFs declined. As of February 6, 2026, the net values of 30 - year treasury - bond ETF, policy - financial bond ETF, 0 - 4 - year local - bond ETF, corporate - bond ETF, short - term financing ETF, urban investment - bond ETF, and convertible - bond ETF changed by 0.68%, 0.23%, 0.06%, 0.03%, 0.04%, 0.03%, and - 0.02% respectively compared to the close on January 30, 2026 [21]. 3.3 各基准做市信用债 ETF 份额及净值走势 (Share and Net Value Trends of Each Benchmark Market - Making Credit - Bond ETF) - The shares of existing 8 credit - bond ETFs continued to have a net outflow. As of February 6, 2026, the shares changed by - 2.82%, no change, - 0.91%, no change, - 4.95%, - 1.48%, - 3.74%, and - 2.70% respectively compared to the close on January 30, 2026 [26]. - The net values of the 8 credit - bond ETFs increased slightly. As of February 6, 2026, the net values changed by 0.03%, 0.03%, 0.02%, 0.03%, 0.02%, 0.01%, 0.02%, and 0.01% respectively compared to the close on January 30, 2026 [27]. 3.4 各科创债 ETF 份额及净值走势 (Share and Net Value Trends of Each Science - Innovation Bond ETF) - Most science - innovation bond ETF products had a net outflow of shares. The total net inflow of shares last week was - 67.16 million, a 2.36% decrease from the previous week. The top three products in terms of share size were Science - Innovation Bond ETF Jiashi, Science - Innovation Bond ETF Yinhua, and Science - Innovation Bond ETF Penghua. The top three products with net outflows were Science - Innovation Bond ETF Jiashi, Science - Innovation Bond ETF Huitianfu, and Science - Innovation Bond ETF Fuguo [32][33]. - The net values of science - innovation bond ETFs continued to rise. As of February 6, 2026, the top - ranked products in terms of net value were Science - Innovation Bond ETF Wanjia, Science - Innovation Bond ETF Yongying, and Science - Innovation Bond ETF Huatai Bairui. The median net values of the first - batch and second - batch science - innovation bond ETFs increased by 0.02% and 0.03% respectively compared to the previous week's close [34]. 3.5 上周单只债券 ETF 市场表现情况 (Market Performance of Single Bond ETFs Last Week) - Convertible - bond ETFs led in terms of decline. Most bond ETF product net values increased last week, with 30 - year treasury - bond ETF and 30 - year treasury - bond ETF Boshi leading the increase, up 0.93% and 0.92% respectively. Only convertible - bond ETF and Shanghai - Stock - Exchange Convertible - Bond ETF had a slight decline in net value, down 0.30% and 0.23% respectively [37]. - In terms of premium - discount rates, 30 - year treasury - bond ETF Boshi, 30 - year treasury - bond ETF, and treasury - bond ETF had leading premium rates. Among science - innovation bond ETFs, the premium - discount performance of each product was differentiated, with Science - Innovation Bond ETF Yinhua and Science - Innovation Bond ETF Fuguo having a slight premium [37]. - In terms of scale changes, short - term financing ETF (+3.256 billion yuan), 30 - year treasury - bond ETF (+842 million yuan), and 30 - year treasury - bond ETF Boshi (+831 million yuan) had the highest net inflow of funds [37]. 3.6 基准做市信用债和科创债 ETF 的 PCF 清单边际变化 (Marginal Changes in the PCF Lists of Benchmark Market - Making Credit - Bond and Science - Innovation Bond ETFs) - The estimated change in the modified duration of Credit - Bond ETF Haifutong was relatively large (- 0.14 years). The average modified duration of new bonds added to the PCF lists of Corporate - Bond ETF Nanfang and Credit - Bond ETF Huaxia was 4.35 years and 1.64 years respectively. For products tracking the Shenzhen - Market - Made Corporate - Bond Index, the average modified duration of new bonds added to the PCF lists of Credit - Bond ETF Guangfa, Credit - Bond ETF Boshi, and Credit - Bond ETF Dacheng was 2.78 years, 2.72 years, and 0.21 years respectively [39]. - Bonds such as 26 Zhongjin K1, Shanmei KY07, and 24 Yankuang K4 were repeatedly included in the PCF lists of benchmark market - making credit - bond ETFs, mainly from industries such as Coal II, Non - Banking Finance, Construction, and Public Utilities II. Bonds such as 24 Baju K1, 24 Zhongmei K2, and 25 Zhaozheng K2 were repeatedly removed from the PCF lists of benchmark market - making credit - bond ETFs [40]. - The estimated changes in the modified durations of Science - Innovation Bond ETF Tianhong and Science - Innovation Bond ETF Jiashi were relatively large, - 0.12 years and - 0.09 years respectively. The average modified duration of new bonds added to the PCF list of Science - Innovation Bond ETF Tianhong was significantly longer than that of similar bonds, at 6.53 years. The average modified duration of new bonds added to the PCF list of Science - Innovation Bond ETF Boshi was significantly shorter than that of similar bonds, at 2.26 years [43]. - Bonds such as 25 Zhezi K2, 25CHNG2K, and Jingzi K14 were repeatedly included in the PCF lists of science - innovation bond ETFs, while bonds such as 23 Yuehuanbao K1, 24TCLK1, and 25 Jingzi K2 were removed from multiple science - innovation bond ETFs [45].

Group 1: Consumer Building Materials - The demand for traditional building materials is expected to rebound as the contraction in new real estate demand slows and the demand for stock updates gradually releases [1] - In 2025, national fixed asset investment (excluding rural households) is projected to be 48.5 trillion yuan, a year-on-year decrease of 3.8%, while real estate development investment is expected to be 8.28 trillion yuan, down 17.2% year-on-year [1] - The area of new housing starts is expected to decline by 20.4% year-on-year to 588 million square meters, only 25.87% of the peak value in 2019, indicating that the drag on demand from the new real estate market has been fully reflected [1] - The stock market for urban residential properties in China is approximately 33.55 billion square meters, with about 37.4 million housing units, indicating significant growth potential for renovation and upgrading of existing properties [1] - Policies aimed at stimulating demand for commercial housing, such as "stopping the decline and stabilizing" and "ensuring delivery," are expected to support the completion and sales of commercial housing [1] Group 2: Fiberglass Industry - The downstream application fields of fiberglass continue to expand, and the product structure of the industry is continuously optimized, with strong demand for specialty fiberglass fabrics such as electronic fiberglass cloth [2] - The industry is expected to see continuous improvement in profitability due to the explosive demand for computing power, leading to tight supply of specialty fiberglass fabrics like low-dielectric electronic cloth [2] - The overall price level of the industry is on the rise, and leading companies are expected to benefit significantly from industry dividends [2] Group 3: Infrastructure Demand - During the 14th Five-Year Plan, it is expected that over 700,000 kilometers of underground pipeline networks will be constructed and renovated, with new investment demand exceeding 5 trillion yuan [3] - There is a broad demand for upgrading and renovating underground pipeline networks for urban gas, water supply, sewage, drainage, and heating [3] Group 4: Companies with Second Growth Curve - Jinjing Technology (600586.SH) is expected to benefit from the significant production ramp-up in the downstream perovskite photovoltaic component industry, indicating broad future growth potential [4] - Puyang Refractories (002225.SZ) is expected to benefit from the demand space created by the replacement of wet metallurgy technology paths, with performance expected to be realized as production capacity is released [4] - Companies like Jinjing Technology and Puyang Refractories are recommended as they show significant incremental potential in their second growth curves [4]